Behavioural and sleep issues after initiation of elexacaftor-tezacaftor-ivacaftor in preschool-age children with cystic fibrosis
- PMID: 38950554
- DOI: 10.1016/S0140-6736(24)01134-6
Behavioural and sleep issues after initiation of elexacaftor-tezacaftor-ivacaftor in preschool-age children with cystic fibrosis
Comment on
-
The future of cystic fibrosis treatment: from disease mechanisms to novel therapeutic approaches.Lancet. 2023 Sep 30;402(10408):1185-1198. doi: 10.1016/S0140-6736(23)01608-2. Epub 2023 Sep 9. Lancet. 2023. PMID: 37699417 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
